SOLUTIONS TO AMERICA'S OTHER DRUG PROBLEM
Cerner Innovation, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75469636 |
| Registration Number | 2686847 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Attorney Name | JASON S. FELDMAN |
| Law Office Assigned | M60 |
| Employee Name | KIM, YONG OH |
Timeline
| 1997-12-09 | Date of First Use |
| 1998-04-17 | Application Filed |
| 1999-11-16 | Published for Opposition |
| 2003-02-11 | Trademark Registered |
| 2008-04-03 | Location: SCANNING ON DEMAND |
| 2009-09-19 | Cancelled |
| 2009-09-19 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CERNER INNOVATION, INC. |
| Address | 5750 WEST 95TH STREET, SUITE 310 OVERLAND PARK KS 66207 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Medical drug delivery management system for the preparation and delivery of injectable, intravenous, oral and topical medications to patients consisting of patient monitors, consisting of patient monitors, computer software, and related accessories therefor |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1998-12-16 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 1999-01-14 | 2 CNRT F:First Action |
| EXAMINER'S AMENDMENT MAILED | 1999-06-30 | 3 CNEA F:First Action |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1999-07-15 | 4 CNSA P: |
| NOTICE OF PUBLICATION | 1999-10-15 | 5 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1999-11-16 | 6 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2000-02-15 | 7 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 2000-08-15 | 8 EXT1 S: |
| EXTENSION 1 GRANTED | 2000-10-13 | 9 EX1G S: |
| EXTENSION 2 FILED | 2001-02-12 | 10 EXT2 S: |
| EXTENSION 2 GRANTED | 2001-03-14 | 11 EX2G S: |
| EXTENSION 3 FILED | 2001-08-15 | 12 EXT3 S: |
| EXTENSION 3 GRANTED | 2001-08-28 | 13 EX3G S: |
| EXTENSION 4 FILED | 2002-02-15 | 14 EXT4 S: |
| EXTENSION 4 GRANTED | 2002-03-02 | 15 EX4G S: |
| USE AMENDMENT FILED | 2002-02-15 | 16 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2002-03-02 | 17 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2002-03-06 | 18 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2002-04-05 | 19 CNRT O:Outgoing Correspondence |
| PAPER RECEIVED | 2002-08-05 | 20 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-08-05 | 21 CRFA I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2002-12-09 | 22 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2003-02-11 | 23 R.PR A:Allowance for Publication |
| CASE FILE IN TICRS | 2008-04-03 | 24 CFIT O:Outgoing Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2009-09-19 | 25 C8.. O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 